Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Muscarinic acetylcholine receptors are transmitters of peripheral and central cholinergic nerves and act specifically on all kinds of choline receptors. Muscarinic acetylcholine receptors play an important role in the treatment of chronic obstructive pulmonary disease, Alzheimer's disease and mental illness. The pharmacological effects of acetylcholine include: slow heart rate, dilation of some blood vessels, weakened contractility of myocardium, decreased blood pressure, and excitement of smooth muscles in gastrointestinal tract, urinary tract and bronchus.
The global Muscarinic Acetylcholine Receptor market report offered by Global Market Monitor provides a detailed analysis of the main driving factors, market trends, business opportunities, threats and challenges of specialty fungicides. This report uses many scientific research methods and collects and organizes important industry-related data. The report provides decisive opinions on market prospects based on leading companies, market size during the forecast period, market share, segmented research, current market trends, activities and major geographic regions. This report provides historical data on market size, compound annual growth value, key company profiles, and analyzes the impact of stakeholders on the Muscarinic Acetylcholine Receptor industry during the forecast period. Through this report, practitioners can have a comprehensive understanding of product knowledge, analyze the current situation of market competition, and devote their precious time to product launches and formulating marketing strategies.
Muscarinic acetylcholine receptors play an important role in the treatment of chronic obstructive pulmonary disease, Alzheimer's disease and mental illness. The rising incidence of these diseases will increase the demand for muscarinic acetylcholine receptors. In addition, increased research and development activities for the therapeutic effects of these receptors will help promote market growth. However, strict government supervision will inhibit this growth. During the forecast period, the muscarinic acetylcholine market will maintain steady growth and reach a considerable compound annual growth rate.
The report details the trend, potential and market size of Muscarinic Acetylcholine Receptor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Muscarinic Acetylcholine Receptormarket, defines the market attractiveness level of Muscarinic Acetylcholine Receptor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Muscarinic Acetylcholine Receptor industry, describes the types of Muscarinic Acetylcholine Receptor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Muscarinic Acetylcholine Receptor market and the development prospects and opportunities of Muscarinic Acetylcholine Receptor industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Muscarinic Acetylcholine Receptor market in Chapter 13.
By Player:
AstraZeneca Plc
Karuna Pharmaceuticals Inc
Anavex Life Sciences Corp
Heptares Therapeutics Ltd
NeuroHealing Pharmaceuticals Inc
Sumitomo Dainippon Pharma Co Ltd
By Type:
M1
M4
M5
Others
By End-User:
Attention Deficit Hyperactivity Disorder
Psychiatric Disorders
Alzheimer's Disease
Chronic Obstructive Pulmonary Disease
Memory Impairment
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Muscarinic Acetylcholine Receptor Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Muscarinic Acetylcholine Receptor Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Muscarinic Acetylcholine Receptor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Muscarinic Acetylcholine Receptor Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Muscarinic Acetylcholine Receptor Market Analysis and Outlook to 2022
-
7.1 Global Muscarinic Acetylcholine Receptor Consumption (2017-2022)
-
7.2 United States Muscarinic Acetylcholine Receptor Consumption (2017-2022)
-
7.3 Europe Muscarinic Acetylcholine Receptor Consumption (2017-2022)
-
7.4 China Muscarinic Acetylcholine Receptor Consumption (2017-2022)
-
7.5 Japan Muscarinic Acetylcholine Receptor Consumption (2017-2022)
-
7.6 India Muscarinic Acetylcholine Receptor Consumption (2017-2022)
-
7.7 South Korea Muscarinic Acetylcholine Receptor Consumption (2017-2022)
8 Region and Country-wise Muscarinic Acetylcholine Receptor Market Analysis and Outlook to 2028
-
8.1 Global Muscarinic Acetylcholine Receptor Consumption Forecast (2022-2028)
-
8.2 United States Muscarinic Acetylcholine Receptor Consumption Forecast (2022-2028)
-
8.3 Europe Muscarinic Acetylcholine Receptor Consumption Forecast (2022-2028)
-
8.4 China Muscarinic Acetylcholine Receptor Consumption Forecast (2022-2028)
-
8.5 Japan Muscarinic Acetylcholine Receptor Consumption Forecast (2022-2028)
-
8.6 India Muscarinic Acetylcholine Receptor Consumption Forecast (2022-2028)
-
8.7 South Korea Muscarinic Acetylcholine Receptor Consumption Forecast (2022-2028)
9 Global Muscarinic Acetylcholine Receptor Market Outlook by Types and Applications to 2022
-
9.1 Global Muscarinic Acetylcholine Receptor Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global M1 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global M4 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global M5 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Muscarinic Acetylcholine Receptor Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Attention Deficit Hyperactivity Disorder Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Psychiatric Disorders Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Chronic Obstructive Pulmonary Disease Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Memory Impairment Consumption and Growth Rate (2017-2022)
10 Global Muscarinic Acetylcholine Receptor Market Outlook by Types and Applications to 2028
-
10.1 Global Muscarinic Acetylcholine Receptor Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global M1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global M4 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global M5 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Muscarinic Acetylcholine Receptor Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Attention Deficit Hyperactivity Disorder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Psychiatric Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Chronic Obstructive Pulmonary Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Memory Impairment Consumption Forecast and Growth Rate (2022-2028)
11 Global Muscarinic Acetylcholine Receptor Import and Export Analysis (Top 5 Countries)
-
11.1 Global Muscarinic Acetylcholine Receptor Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Muscarinic Acetylcholine Receptor Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Muscarinic Acetylcholine Receptor Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Muscarinic Acetylcholine Receptor Market Competitive Analysis
-
14.1 AstraZeneca Plc
-
14.1.1 AstraZeneca Plc Company Details
-
14.1.2 AstraZeneca Plc Muscarinic Acetylcholine Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Plc Muscarinic Acetylcholine Receptor Product and Service
-
14.2 Karuna Pharmaceuticals Inc
-
14.2.1 Karuna Pharmaceuticals Inc Company Details
-
14.2.2 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product and Service
-
14.3 Anavex Life Sciences Corp
-
14.3.1 Anavex Life Sciences Corp Company Details
-
14.3.2 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Product and Service
-
14.4 Heptares Therapeutics Ltd
-
14.4.1 Heptares Therapeutics Ltd Company Details
-
14.4.2 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Product and Service
-
14.5 NeuroHealing Pharmaceuticals Inc
-
14.5.1 NeuroHealing Pharmaceuticals Inc Company Details
-
14.5.2 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product and Service
-
14.6 Sumitomo Dainippon Pharma Co Ltd
-
14.6.1 Sumitomo Dainippon Pharma Co Ltd Company Details
-
14.6.2 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Muscarinic Acetylcholine Receptor
-
Figure Muscarinic Acetylcholine Receptor Picture
-
Table Global Muscarinic Acetylcholine Receptor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Muscarinic Acetylcholine Receptor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Muscarinic Acetylcholine Receptor Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Muscarinic Acetylcholine Receptor Consumption by Country (2017-2022)
-
Figure United States Muscarinic Acetylcholine Receptor Consumption and Growth Rate (2017-2022)
-
Table Europe Muscarinic Acetylcholine Receptor Consumption and Growth Rate (2017-2022)
-
Figure China Muscarinic Acetylcholine Receptor Consumption and Growth Rate (2017-2022)
-
Figure Japan Muscarinic Acetylcholine Receptor Consumption and Growth Rate (2017-2022)
-
Figure India Muscarinic Acetylcholine Receptor Consumption and Growth Rate (2017-2022)
-
Figure South Korea Muscarinic Acetylcholine Receptor Consumption and Growth Rate (2017-2022)
-
Figure Global Muscarinic Acetylcholine Receptor Consumption Forecast by Country (2022-2028)
-
Figure United States Muscarinic Acetylcholine Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Muscarinic Acetylcholine Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Muscarinic Acetylcholine Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Muscarinic Acetylcholine Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Muscarinic Acetylcholine Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Muscarinic Acetylcholine Receptor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global M1 Consumption and Growth Rate (2017-2022)
-
Figure Global M4 Consumption and Growth Rate (2017-2022)
-
Figure Global M5 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Attention Deficit Hyperactivity Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Psychiatric Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Obstructive Pulmonary Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Memory Impairment Consumption and Growth Rate (2017-2022)
-
Figure Global M1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global M4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global M5 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Attention Deficit Hyperactivity Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psychiatric Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Obstructive Pulmonary Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Memory Impairment Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Muscarinic Acetylcholine Receptor Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Muscarinic Acetylcholine Receptor Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc Muscarinic Acetylcholine Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc Muscarinic Acetylcholine Receptor Product and Service
-
Table Karuna Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product and Service
-
Table Anavex Life Sciences Corp (Foundation Year, Company Profile and etc.)
-
Table Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Product and Service
-
Table Heptares Therapeutics Ltd (Foundation Year, Company Profile and etc.)
-
Table Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Product and Service
-
Table NeuroHealing Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product and Service
-
Table Sumitomo Dainippon Pharma Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Product and Service
-
